Cargando…

What is the role of sentinel lymph node biopsy in the management of oral cancer in 2020?

Approximately 70–80% of patients with cT1-2N0 oral squamous cell carcinoma (OSCC) ultimately prove to have no cancer in the cervical lymphatics on final pathology after selective neck dissection. As a result, sentinel lymph node biopsy (SLNB) has been adopted during the last decade as a diagnostic s...

Descripción completa

Detalles Bibliográficos
Autores principales: de Bree, Remco, de Keizer, Bart, Civantos, Francisco J., Takes, Robert P., Rodrigo, Juan P., Hernandez-Prera, Juan C., Halmos, Gyorgy B., Rinaldo, Alessandra, Ferlito, Alfio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8328894/
https://www.ncbi.nlm.nih.gov/pubmed/33369691
http://dx.doi.org/10.1007/s00405-020-06538-y
_version_ 1783732394715512832
author de Bree, Remco
de Keizer, Bart
Civantos, Francisco J.
Takes, Robert P.
Rodrigo, Juan P.
Hernandez-Prera, Juan C.
Halmos, Gyorgy B.
Rinaldo, Alessandra
Ferlito, Alfio
author_facet de Bree, Remco
de Keizer, Bart
Civantos, Francisco J.
Takes, Robert P.
Rodrigo, Juan P.
Hernandez-Prera, Juan C.
Halmos, Gyorgy B.
Rinaldo, Alessandra
Ferlito, Alfio
author_sort de Bree, Remco
collection PubMed
description Approximately 70–80% of patients with cT1-2N0 oral squamous cell carcinoma (OSCC) ultimately prove to have no cancer in the cervical lymphatics on final pathology after selective neck dissection. As a result, sentinel lymph node biopsy (SLNB) has been adopted during the last decade as a diagnostic staging method to intelligently identify patients who would benefit from formal selective lymphadenectomy or neck irradiation. While not yet universally accepted, SLNB is now incorporated in many national guidelines. SLNB offers a less invasive alternative to elective neck dissection (END), and has some advantages and disadvantages. SLNB can assess the individual drainage pattern and, with step serial sectioning and immunohistochemistry (IHC), can enable the accurate detection of micrometastases and isolated tumor cells (ITCs). Staging of the neck is improved relative to END with routine histopathological examination. The improvements in staging are particularly notable for the contralateral neck and the pretreated neck. However, for floor of mouth (FOM) tumors, occult metastases are frequently missed by SLNB due to the proximity of activity from the primary site to the lymphatics (the shine through phenomenon). For FOM cancers, it is advised to perform either elective neck dissection or superselective neck dissection of the preglandular triangle of level I. New tracers and techniques under development may improve the diagnostic accuracy of SLNB for early-stage OSCC, particularly for FOM tumors. Treatment of the neck (either neck dissection or radiotherapy), although limited to levels I–IV, remains mandatory for any positive category of metastasis (macrometastasis, micrometastasis, or ITCs). Recently, the updated EANM practical guidelines for SLN localization in OSCC and the surgical consensus guidelines on SLNB in patients with OSCC were published. In this review, the current evidence and results of SLNB in early OSCC are presented.
format Online
Article
Text
id pubmed-8328894
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-83288942021-08-20 What is the role of sentinel lymph node biopsy in the management of oral cancer in 2020? de Bree, Remco de Keizer, Bart Civantos, Francisco J. Takes, Robert P. Rodrigo, Juan P. Hernandez-Prera, Juan C. Halmos, Gyorgy B. Rinaldo, Alessandra Ferlito, Alfio Eur Arch Otorhinolaryngol Review Article Approximately 70–80% of patients with cT1-2N0 oral squamous cell carcinoma (OSCC) ultimately prove to have no cancer in the cervical lymphatics on final pathology after selective neck dissection. As a result, sentinel lymph node biopsy (SLNB) has been adopted during the last decade as a diagnostic staging method to intelligently identify patients who would benefit from formal selective lymphadenectomy or neck irradiation. While not yet universally accepted, SLNB is now incorporated in many national guidelines. SLNB offers a less invasive alternative to elective neck dissection (END), and has some advantages and disadvantages. SLNB can assess the individual drainage pattern and, with step serial sectioning and immunohistochemistry (IHC), can enable the accurate detection of micrometastases and isolated tumor cells (ITCs). Staging of the neck is improved relative to END with routine histopathological examination. The improvements in staging are particularly notable for the contralateral neck and the pretreated neck. However, for floor of mouth (FOM) tumors, occult metastases are frequently missed by SLNB due to the proximity of activity from the primary site to the lymphatics (the shine through phenomenon). For FOM cancers, it is advised to perform either elective neck dissection or superselective neck dissection of the preglandular triangle of level I. New tracers and techniques under development may improve the diagnostic accuracy of SLNB for early-stage OSCC, particularly for FOM tumors. Treatment of the neck (either neck dissection or radiotherapy), although limited to levels I–IV, remains mandatory for any positive category of metastasis (macrometastasis, micrometastasis, or ITCs). Recently, the updated EANM practical guidelines for SLN localization in OSCC and the surgical consensus guidelines on SLNB in patients with OSCC were published. In this review, the current evidence and results of SLNB in early OSCC are presented. Springer Berlin Heidelberg 2020-12-28 2021 /pmc/articles/PMC8328894/ /pubmed/33369691 http://dx.doi.org/10.1007/s00405-020-06538-y Text en © The Author(s) 2020 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Review Article
de Bree, Remco
de Keizer, Bart
Civantos, Francisco J.
Takes, Robert P.
Rodrigo, Juan P.
Hernandez-Prera, Juan C.
Halmos, Gyorgy B.
Rinaldo, Alessandra
Ferlito, Alfio
What is the role of sentinel lymph node biopsy in the management of oral cancer in 2020?
title What is the role of sentinel lymph node biopsy in the management of oral cancer in 2020?
title_full What is the role of sentinel lymph node biopsy in the management of oral cancer in 2020?
title_fullStr What is the role of sentinel lymph node biopsy in the management of oral cancer in 2020?
title_full_unstemmed What is the role of sentinel lymph node biopsy in the management of oral cancer in 2020?
title_short What is the role of sentinel lymph node biopsy in the management of oral cancer in 2020?
title_sort what is the role of sentinel lymph node biopsy in the management of oral cancer in 2020?
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8328894/
https://www.ncbi.nlm.nih.gov/pubmed/33369691
http://dx.doi.org/10.1007/s00405-020-06538-y
work_keys_str_mv AT debreeremco whatistheroleofsentinellymphnodebiopsyinthemanagementoforalcancerin2020
AT dekeizerbart whatistheroleofsentinellymphnodebiopsyinthemanagementoforalcancerin2020
AT civantosfranciscoj whatistheroleofsentinellymphnodebiopsyinthemanagementoforalcancerin2020
AT takesrobertp whatistheroleofsentinellymphnodebiopsyinthemanagementoforalcancerin2020
AT rodrigojuanp whatistheroleofsentinellymphnodebiopsyinthemanagementoforalcancerin2020
AT hernandezprerajuanc whatistheroleofsentinellymphnodebiopsyinthemanagementoforalcancerin2020
AT halmosgyorgyb whatistheroleofsentinellymphnodebiopsyinthemanagementoforalcancerin2020
AT rinaldoalessandra whatistheroleofsentinellymphnodebiopsyinthemanagementoforalcancerin2020
AT ferlitoalfio whatistheroleofsentinellymphnodebiopsyinthemanagementoforalcancerin2020